Venturi Wealth Management LLC Purchases 206 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

Venturi Wealth Management LLC lifted its position in shares of ICU Medical, Inc. (NASDAQ:ICUI) by 64.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 528 shares of the medical instruments supplier’s stock after buying an additional 206 shares during the quarter. Venturi Wealth Management LLC’s holdings in ICU Medical were worth $82,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in the company. Creative Planning lifted its stake in ICU Medical by 58.6% in the third quarter. Creative Planning now owns 6,193 shares of the medical instruments supplier’s stock worth $1,128,000 after acquiring an additional 2,287 shares during the period. Sequoia Financial Advisors LLC purchased a new stake in shares of ICU Medical in the 3rd quarter worth approximately $442,000. Greenleaf Trust bought a new position in shares of ICU Medical during the third quarter valued at approximately $207,000. Allworth Financial LP boosted its stake in shares of ICU Medical by 100.0% during the third quarter. Allworth Financial LP now owns 200 shares of the medical instruments supplier’s stock valued at $36,000 after purchasing an additional 100 shares in the last quarter. Finally, Louisiana State Employees Retirement System increased its holdings in ICU Medical by 14.6% during the third quarter. Louisiana State Employees Retirement System now owns 11,800 shares of the medical instruments supplier’s stock valued at $2,150,000 after buying an additional 1,500 shares during the period. Hedge funds and other institutional investors own 96.10% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on ICUI. Needham & Company LLC restated a “hold” rating on shares of ICU Medical in a report on Wednesday, November 13th. StockNews.com upgraded ICU Medical from a “hold” rating to a “buy” rating in a research note on Wednesday, November 20th. Jefferies Financial Group raised ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 price objective on the stock in a research report on Wednesday, December 11th. Finally, KeyCorp boosted their target price on shares of ICU Medical from $198.00 to $209.00 and gave the stock an “overweight” rating in a report on Wednesday, November 13th. One investment analyst has rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat, ICU Medical has a consensus rating of “Moderate Buy” and an average price target of $199.67.

ICU Medical Stock Performance

Shares of ICUI opened at $157.42 on Monday. The company has a current ratio of 2.29, a quick ratio of 1.03 and a debt-to-equity ratio of 0.75. The firm has a market cap of $3.85 billion, a PE ratio of -34.45 and a beta of 0.63. ICU Medical, Inc. has a 12 month low of $93.36 and a 12 month high of $196.26. The stock has a fifty day moving average price of $160.74 and a 200-day moving average price of $166.22.

Insider Activity at ICU Medical

In other news, CEO Vivek Jain sold 1,373 shares of the company’s stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $155.48, for a total transaction of $213,474.04. Following the transaction, the chief executive officer now owns 104,593 shares in the company, valued at $16,262,119.64. This represents a 1.30 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, COO Christian B. Voigtlander sold 1,430 shares of the stock in a transaction that occurred on Wednesday, November 27th. The shares were sold at an average price of $158.00, for a total transaction of $225,940.00. The disclosure for this sale can be found here. Insiders have sold 15,775 shares of company stock valued at $2,548,017 in the last ninety days. Corporate insiders own 6.70% of the company’s stock.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.